Written Question·Department of Health and Social Care·UIN 76429
Obesity: Drugs
Tabled: 10 September 2025
Answered: 22 September 2025
Question
Sarah Hall
Labour (Co-op) — Warrington South
To ask the Secretary of State for Health and Social Care, when he plans to expand prescribing of GLP-1 medications beyond specialist weight-management services.
Answer
Dr Zubir AhmedNational Institute for Health and Care Excellence (NICE) guidance on the first two GLP-1 medicines licensed for the treatment of obesity, namely liraglutide under various brand names and semaglutide with brand name Wegovy, restricted their use to speciali...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 76429) →